Biologics Facilities Expand and Establish New Locations in 2021

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2021
Volume 2021 eBook
Issue 2
Pages: 60-62

The latest news about biologics facilities includes various expansions, new locations, and acquisitions in the bio/pharmaceutical space.

Biologics facilities have expanded and advanced within the past few months in terms of significant investments, construction on new facilities, and acquisitions of new locations. The following are a sampling of these advances.

Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.

About the Author

Lauren Lavelle is assistant editor of Pharmaceutical Technology.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 60–62

Citation

When referring to this article, please cite it as L. Lavelle, “Biologics Facilities Expand and Establish New Locations in 2021," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).

Articles in this issue
IVAN TRAIMAK - STOCK.ADOBE.COM
Sterile Filtration: Reducing Risk, Ensuring Safety
nordroden - stock.adobe.com
Filling Small Batches
Vangelis Vassalakis - Stock.adobe.com
Breaking the Cold Chain for Vaccines
Kateryna_Kon/Stock.adobe.com – Image of Mycoplasma bacteria
Using ddPCR to Detect Mycoplasma Contamination
DARIAREN - STOCK.ADOBE.COM
The Impact of COVID-19 on Biologics Regulations
liga258 - Stock.adobe.com
Packaging Biologic Drugs for Clinical Trials
Daniel - stock.adobe.com
Tracking Technologies Guard Vaccine Cold Chain
Eyeing Up Success in Fill/Finish
Eyeing Up Success in Fill/Finish
ALEXNGM - STOCK.ADOBE.COM
Reducing Packaging Costs for Prefilled Syringes
putilov_denis - Stock.adobe.com
Biologics Facilities Expand and Establish New Locations in 2021
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease

Felicity Thomas
November 16th 2024
Article

CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics

Feliza Mirasol
November 15th 2024
Article

Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Merck and Ginkgo Bioworks’ Collaboration to Improve Biologics Manufacturing Has Reached Its First Milestone

Feliza Mirasol
November 13th 2024
Article

Under an ongoing partnership with Merck, known as MSD outside of the United States and Canada, Ginkgo Bioworks has achieved the first milestone in a project aimed at improving biologics production.